How many insider disclosures are linked to CITIUS ONCOLOGY, INC.?

Available records link 32 public disclosures to CITIUS ONCOLOGY, INC., sourced from SEC (Form 4).

Who is the top reporting insider at CITIUS ONCOLOGY, INC.?

The top reporting insider at CITIUS ONCOLOGY, INC. is HOLUBIAK MYRON Z, based on the count of public filings.

What declared insider buy and sell totals are available for CITIUS ONCOLOGY, INC.?

Across the available history, declared buys total 0 and disposals 0.

InsiderTradesSIGMA

InsidersTradesSigma

← Companies ★ Sign in to follow

CITIUS ONCOLOGY, INC. Stock: price and insider trades · United States · SEC (Form 4)

Source idSEC:citius-oncology-inc-a83faa·SEC (Form 4)Mcap US$68.6M

SEC (Form 4)

Track the CITIUS ONCOLOGY, INC. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €68.6m. The latest transaction was disclosed on 22 December 2025 (Attribution). Among the most active insiders: HOLUBIAK MYRON Z. The full history is accessible without an account.

Insider Decl.

n/a

Thresholds

n/a

Buy Volume

n/a

Sell Volume

Analyst consensus: bullish or bearish?

Analysts rate CITIUS ONCOLOGY, INC. Buy (bullish), based on 1 analysts. Average price target: US$4.00.

Sigma AI Analysis

Fundamental view, insider signal, bull and bear case, synthesis.

AI analysis generation is paused.

Last declaration on 22 December 2025

Declarations32 total

◆

Webb Carol

DirectorExecutives19 Sept 2025

CITIUS ONCOLOGY, INC. Stock: price and insider trades · United States · SEC (Form 4)

Analyst consensus: bullish or bearish?

关于 CITIUS ONCOLOGY, INC.

Related companies and executives

CITIUS ONCOLOGY, INC. Stock: price and insider trades · United States · SEC (Form 4)

Analyst consensus: bullish or bearish?

关于 CITIUS ONCOLOGY, INC.

Related companies and executives